opnt002
Generic: nasal naltrexone·Code: OPNT002
opnt002: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| OPIANT PHARMACEUTICALS, INC. (OPNT) | Phase 2 |
Get deeper analysis on opnt002
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis